Your browser does not support JavaScript!

Esco VacciXcell News

Corporate Press Release

COVID-19 Response: A letter to our customers

The COVID-19 pandemic has been dominating global headlines in recent times. It is indeed worrying for everyone, and it is uncertain how the ...

March 23, 2020

A Tide to Remember

Throughout 2018, Esco Aster and Esco VacciXcell have been very determined in providing solutions through the use of proprietary technologies...

December 7, 2018

Esco Healthcare Welcomes 2018!

Esco Healthcare, a member of the Esco Group of companies, is comprised of 3 divisions namely, Esco Pharma, TaPestle Rx, and Esco VacciXcell....

January 5, 2018

ESCO ASTER AND INSTITUTE OF MOLECULAR CELL BIOLOGY ANNOUNCE A COLLABORATION TO ACCELERATE PRECLINICAL DEVELOPMENT OF A HAND FOOT AND MOUTH VACCINE

Singapore, December 07, 2018 - Esco Aster, a leading independent contract development and manufacturing organization dedicated to the Singap...

December 8, 2017

Introducing Aster BioPharma Contract Development and Manufacturing Organization (CDMO)

A CDMO or Contract Development and Manufacturing Organization is a contractual company that provides services like drug development and drug...

June 15, 2017

Know Why Industries are Going with the New Tide

Cell culture using mammalian cells has been used in bioprocessing and biopharmaceutical to produce a variety of life saving products. Mammal...

March 8, 2017

Innovations and Advances for Bioprocessing Seminar, Hong Kong

Esco VacciXcell successfully conducted a seminar last January 20, 2017 in HKPC Building, 78 Tat Chee Aveneu, Kowloon Tong, Hong Kong. Lead b...

February 1, 2017

FEATURED CLIENT: MEDIGEN VACCINE BIOLOGICS CO

In 2009, the H1N1 pandemic was bringing panic to the whole world due to its infection rate and lethality. In response to this threat, Medige...

January 27, 2017